Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Ablatherm-HIFU Patient Highlights Positive Treatment Experience
***Please view using updated link below*** October 5, 2009 We are pleased to announce that WRAL-TV (CBS affiliate) in Raleigh, North Carolina recently aired a piece on EDAP's ongoing clinical trial of Ablatherm High-Intensity Focused Ultrasound (HIFU) as a robotized, non-invasive treatment in
View HTML
Toggle Summary EDAP Enhances Ablatherm-HIFU European Marketing Strategy
LYON, France, Sep 23, 2009 (GlobeNewswire via COMTEX News Network) -- EDAP TMS S.A. (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today the launch of an intensified communication and education strategy in France, aimed at increasing physician and patient awareness of
View HTML
Toggle Summary EDAP Successfully Expands HIFU Business and Approval in New Territories
LYON, France, Sep 10, 2009 (GlobeNewswire via COMTEX News Network) -- EDAP TMS S.A. (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today the expansion of Ablatherm-HIFU into new territories as part of the Company's global growth strategy: * The Taiwan Department of Health
View HTML
Toggle Summary EDAP Reports Second Quarter 2009 Financial Results
Second Quarter 2009 Highlights: * Year-over-year comparisons, Sep 1, 2009 (GlobeNewswire via COMTEX News Network) -- Total revenue of EUR 6.8 million, up 37.0% -- Total HIFU revenue of EUR 2.2 million, up 34.2% -- Ablatherm-HIFU revenue per procedure (RPP) treatments increased 34.9% -- Total
View HTML
Toggle Summary EDAP Receives U.S. FDA 510(k) Approval for Sonolith I-Sys
Novel, Innovative and Robotized Next-Generation Lithotripsy Device to Enter U.S. Market
View HTML
Toggle Summary EDAP Announces Webcast and Conference Call of Second Quarter 2009 Results
LYON, France, Aug 12, 2009 (GlobeNewswire via COMTEX News Network) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today details relating to its second quarter 2009 earnings announcement, which will take place on Tuesday, September 1, 2009, before the opening of
View HTML
Toggle Summary EDAP Announces New Board Member
U.S. Industry Veteran Rob Michiels Elected Director
View HTML
Toggle Summary EDAP Expands U.S. ENLIGHT Clinical Trial Team to Accelerate Patient Enrollment
Jul 13, 2009 (GlobeNewswire via COMTEX News Network) -- U.S. Urologist Dr. Douglas Chinn Named Clinical Instructor First Ablatherm-HIFU Patient Treated At Memorial Sloan-Kettering Cancer Center LYON, France, July 13, 2009 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in
View HTML
Toggle Summary EDAP Appoints U.S. Urologist Dr. Argil Wheelock to Board of Directors
LYON, France, Jun 26, 2009 (GlobeNewswire via COMTEX News Network) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that Dr. Argil J. Wheelock, MD was appointed to its Board of Directors, effective June 25, 2009. Dr. Wheelock replaces Dr.
View HTML
Toggle Summary EDAP Highlights HIFU Focal Therapy for Treatment of Prostate Cancer
Ablatherm-HIFU Highlighted as Superior Non-Invasive Focal Therapy; Awarded Best Poster for Long-Term Focal Therapy Results
View HTML